FinancialContent is the trusted provider of stock market information to the media industry
Stroke Drug From Pfizer, Bristol-Myers Hits Snag
Posted on June 25, 2012 at 10:53 AM EDT
Shares of Pfizer (PFE) and Bristol-Myers Squibb (BMY) tumbled early Monday, as the FDA asked for more information on a key drug up for approval. The companies hoped that the agency would approve their stroke-prevention drug Eliquis this month, but instead the FDA sent a letter asking for more details on how researchers conducted a certain clinical trial. It did not ask for new studies, which would have entailed a longer delay. Eliquis is one of a
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here